Hinge Health Inc.

HNGE | NYSE

Price Alert Chart Builder DCF Calculator

$114.32

-$2.58 (-2.21%)

At close: Oct 30, 2026, 4:00 PM ET

$115.10

+$0.78 (+0.68%)

Pre-market: Nov 2, 2026, 7:12 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.21%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

74.7

+5.5 pts

Fundamentals Excellent

Market Sentiment Bullish

Moat Narrow

Sector Rank #34/1028 (Top 3%)

Full Analysis

Key Statistics

Market Data

Market Cap $9.22B

1D Range

111.43 115.80

52W Range

31.17 115.80

Valuation (TTM)

PE 88.62

PB 26.79

EV/EBITDA 85.93

Valuation (NTM)

Forward PE 35.97

Forward PEG 1.42

Price Target $103.92

Cash Flow

FCF Yield 3.1%

SBC Adj. FCF Yield 2.2%

SBC Impact -28.8%

Margins

Gross Margin 84.5%

Operating Margin 13.0%

FCF Margin 39.9%

Growth (CAGR)

Revenue 3Y | 5Y 117.7% | N/A

Dil EPS 3Y | 5Y 66.2% | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA 13.2%

ROE 30.3%

ROIC 26.3%

Financial Health

Net Cash

$389.39M

Current Ratio 1.34

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform i...

Sector Healthcare

Industry Medical - Healthcare Information Services

Employees 1,437

IPO Date May 22, 2025

Website www.hingehealth.com

Fiscal Year January - December

Full Company Profile

Latest News

3 days ago · zacks.com

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

28 days ago · gurufocus.com

Hinge Health to announce third quarter 2026 financial results on November 2, 2026

Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial mar

1 month ago · marketbeat.com

3 Healthcare Stocks Showing Why the Sector Still Has Momentum

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.

2 months ago · fool.com

Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876

The transaction reduced her direct equity position by 4% while maintaining a multi-million dollar stake in the company. This disposition involved directly held shares only, with no indirect holdings reported in the filing.

2 months ago · zacks.com

Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?

2 months ago · investors.com

IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points

Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points despite market weakness.

2 months ago · marketbeat.com

One Platform, Every Ailment: Hinge Health's Gamble

Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.

2 months ago · zacks.com

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.